Hugh Ekengren
Family Medicine · Wichita, KSNPI 1437111994
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $420 and has fallen 95.9% since, to $17 in 2023.
Across 81 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$248
- Amgen$167
- AbbVie$152
- GSK$72
- Sanofi-aventis U.S. LLC$62
- Novartis$57
- plus $507 from 18 others
What the payments were for
- Food & beverage$1,265100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $248 |
| Amgen | 9 | $167 |
| AbbVie(2 entities) | 10 | $152 |
| GSK | 4 | $72 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Novartis | 3 | $57 |
| Sanofi Pasteur Inc. | 3 | $54 |
| Amarin Pharma, Inc. | 3 | $53 |
| Abbott | 3 | $50 |
| Mylan Specialty L.p. | 3 | $39 |
| Merck | 3 | $37 |
| AstraZeneca | 3 | $34 |
| Astellas Pharma US Inc | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Johnson & Johnson | 2 | $26 |
| Eisai Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Pfizer | 1 | $11 |
How this compares
$1,265 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.